Stocktoria

ORASURE TECHNOLOGIES INC OSUR

Nasdaq · stock · Surgical & Medical Instruments & Apparatus · website · IPO 1986-11-17 · LEI

ORASURE TECHNOLOGIES INC statistics & valuation

Market cap$307.1M
P / S2.7×
P / B0.9×
Net margin-59.8%
Return on equity-20.2%
FCF margin-46.3%
Return on capital-19.8%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
15.40% 18.50% 11.20% 10.80% -8.70% -9.80% -4.40% 13.20% -10.50% -59.80% 2016201720182019202020212022202320242025
Gross margin (%)
68.70% 59.20% 62.50% 61.20% 59.30% 50.30% 38.30% 42.30% 42.70% 41.90% 2016201720182019202020212022202320242025
Operating margin (%)
15.80% 24.10% 15.60% 12.00% -3.00% -4.30% -5.70% 8.10% -15.20% -62.60% 2016201720182019202020212022202320242025
Return on equity (%)
10.60% 12.00% 7.20% 5.40% -3.70% -6.00% -4.70% 12.50% -4.80% -20.20% 2016201720182019202020212022202320242025
Shares outstanding
56.5M 61.0M 62.5M 62.2M 71.7M 72.1M 72.7M 74.4M 74.6M 73.5M 2016201720182019202020212022202320242025
Net debt ($)
2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
9.50% 10.40% 6.50% 4.80% -3.30% -5.00% -3.90% 11.10% -4.10% -17.00% 2016201720182019202020212022202320242025
Free cash flow margin (%)
15.80% 14.30% 18.00% 0.30% -12.20% -24.50% -13.90% 33.50% 12.70% -46.30% 2016201720182019202020212022202320242025
Debt / equity (×)
2016201720182019202020212022202320242025
EPS ($)
$0.35 $0.51 $0.33 $0.27 $0.22 -$0.32 -$0.24 $0.72 -$0.26 -$0.94 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

P / E vs its own history

ORASURE TECHNOLOGIES INC trades at about 5.2× earnings — below its 10-year norm (10-year range 10.2×–69.2×, median 38.9×).

5.2× 69.2×

Shaded band = 10-year range (10.2×–69.2×); dot = today's 5.2×.

Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Gross margin41.9%42.7%42.3%38.3%50.3%59.3%61.2%62.5%59.2%68.7%
Operating margin-62.6%-15.2%8.1%-5.7%-4.3%-3.0%12.0%15.6%24.1%15.8%
Net margin-59.8%-10.5%13.2%-4.4%-9.8%-8.7%10.8%11.2%18.5%15.4%
FCF margin-46.3%12.7%33.5%-13.9%-24.5%-12.2%0.3%18.0%14.3%15.8%
Return on assets-17.0%-4.1%11.1%-3.9%-5.0%-3.3%4.8%6.5%10.4%9.5%
Return on equity-20.2%-4.8%12.5%-4.7%-6.0%-3.7%5.4%7.2%12.0%10.6%
Current ratio6.589.959.774.714.406.216.867.846.889.02

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.